更多...
收起
ADIPOQ基因(以及对应的蛋白质)的细胞分布位置:
ADIPOQ基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.322113216 | 138 | 12 | BeFree_CTD_human_GAD_LHGDN_RGD |
| Obesity | 0.30470121 | 113 | 5 | BeFree_CTD_human_GAD_RGD |
| Insulin Resistance | 0.240239544 | 22 | 0 | CTD_human_GAD_RGD |
| Kidney Failure, Chronic | 0.226628555 | 13 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
| Gestational Diabetes | 0.220427661 | 14 | 5 | BeFree_CTD_human_LHGDN_RGD |
| Non-alcoholic Fatty Liver Disease | 0.201085767 | 7 | 1 | BeFree_CTD_human_RGD |
| Arthritis, Experimental | 0.2 | 2 | 0 | CTD_human_RGD |
| Metabolic Syndrome X | 0.184894604 | 68 | 3 | BeFree_CTD_human_GAD_LHGDN |
| Atherosclerosis | 0.145790485 | 16 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Hypertensive disease | 0.142722629 | 17 | 10 | BeFree_CTD_human_GAD_LHGDN |
| Diabetes Mellitus | 0.142679022 | 41 | 11 | BeFree_CTD_human_GAD_LHGDN |
| Inflammation | 0.138713133 | 8 | 0 | CTD_human_GAD_LHGDN |
| Diabetic Nephropathy | 0.133354191 | 14 | 5 | BeFree_CTD_human_GAD_LHGDN |
| Rheumatoid Arthritis | 0.128715934 | 6 | 2 | BeFree_CTD_human_LHGDN |
| Hyperemia | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
| Myocardial Ischemia | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
| Heart failure | 0.122367032 | 1 | 1 | CTD_human_GAD |
| Crohn Disease | 0.12 | 1 | 0 | CTD_human |
| Heroin Dependence | 0.12 | 1 | 0 | CTD_human |
| Liver Cirrhosis, Experimental | 0.12 | 1 | 0 | CTD_human |
| Myocardial Reperfusion Injury | 0.12 | 1 | 0 | CTD_human |
| Weight Gain | 0.12 | 1 | 0 | CTD_human |
| Drug-Induced Liver Injury | 0.12 | 1 | 0 | CTD_human |
| Coronary Restenosis | 0.12 | 1 | 0 | CTD_human |
| Weight decreased | 0.12 | 1 | 0 | CTD_human |
| ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3 | 0.12 | 1 | 0 | CTD_human |
| ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2 | 0.12 | 1 | 0 | CTD_human |
| ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 | 0.12 | 1 | 0 | UNIPROT |
| Fatty Liver | 0.106628555 | 11 | 0 | BeFree_GAD_LHGDN_RGD |
| Myocardial Infarction | 0.091725539 | 11 | 0 | BeFree_GAD_LHGDN_RGD |
| Hyperinsulinism | 0.082909916 | 3 | 1 | BeFree_GAD_RGD |
| Hyperlipidemia | 0.08272435 | 2 | 0 | LHGDN_RGD |
| Colitis | 0.08 | 1 | 0 | RGD |
| Diabetes Mellitus, Experimental | 0.08 | 1 | 0 | RGD |
| Fetal Growth Retardation | 0.08 | 1 | 0 | RGD |
| Hyperthyroidism | 0.08 | 1 | 0 | RGD |
| Mammary Neoplasms, Experimental | 0.08 | 1 | 0 | RGD |
| Reperfusion Injury | 0.08 | 1 | 0 | RGD |
| Sepsis | 0.08 | 1 | 0 | RGD |
| Endotoxemia | 0.08 | 1 | 0 | RGD |
| Choroidal Neovascularization | 0.08 | 2 | 0 | RGD |
| Brain Infarction | 0.08 | 1 | 0 | RGD |
| Diabetic Cardiomyopathies | 0.08 | 1 | 0 | RGD |
| Coronary Artery Disease | 0.048922633 | 45 | 3 | BeFree_GAD_LHGDN |
| Polycystic Ovary Syndrome | 0.042878849 | 23 | 1 | BeFree_GAD_LHGDN |
| Coronary Arteriosclerosis | 0.021802564 | 31 | 3 | BeFree_GAD |
| Cardiovascular Diseases | 0.0201601 | 22 | 3 | BeFree_GAD_LHGDN |
| Coronary heart disease | 0.017869013 | 31 | 2 | BeFree_GAD_LHGDN |
| Dyslipidemias | 0.014436077 | 8 | 0 | BeFree_LHGDN |
| Colorectal Cancer | 0.012996872 | 14 | 3 | BeFree_GAD |
| Pre-Eclampsia | 0.012549796 | 5 | 0 | GAD_LHGDN |
| Mammary Neoplasms | 0.010897401 | 4 | 0 | LHGDN |
| Vascular Diseases | 0.010811525 | 5 | 5 | BeFree_GAD_LHGDN |
| Diabetes Mellitus, Insulin-Dependent | 0.010639772 | 6 | 0 | BeFree_GAD_LHGDN |
| Impaired glucose tolerance | 0.010073144 | 10 | 3 | BeFree_LHGDN |
| body mass | 0.009468128 | 4 | 0 | GAD |
| Anorexia Nervosa | 0.008444493 | 3 | 0 | BeFree_LHGDN |
| Prostatic Neoplasms | 0.008444493 | 4 | 0 | BeFree_LHGDN |
| Obesity, Morbid | 0.008186863 | 6 | 0 | BeFree_GAD |
| Metabolic Diseases | 0.007891677 | 11 | 1 | BeFree_LHGDN |
| Diabetes | 0.007871814 | 29 | 3 | BeFree |
| Overweight | 0.006634157 | 9 | 0 | BeFree_GAD |
| Chronic Obstructive Airway Disease | 0.006263026 | 5 | 0 | BeFree_LHGDN |
| Colorectal Neoplasms | 0.005720142 | 3 | 0 | BeFree_LHGDN |
| Hyperlipidemia, Familial Combined | 0.005720142 | 3 | 0 | BeFree_LHGDN |
| Malignant neoplasm of prostate | 0.00554839 | 4 | 0 | BeFree_GAD |
| Arteriosclerosis Obliterans | 0.0054487 | 2 | 0 | LHGDN |
| Endometriosis | 0.0054487 | 2 | 0 | LHGDN |
| Stomach Neoplasms | 0.0054487 | 2 | 0 | LHGDN |
| Sleep Apnea, Obstructive | 0.0054487 | 2 | 0 | LHGDN |
| Renal Insufficiency | 0.0054487 | 2 | 0 | LHGDN |
| Diabetic Retinopathy | 0.005362824 | 2 | 0 | BeFree_GAD_LHGDN |
| Liver Cirrhosis | 0.005362824 | 2 | 0 | BeFree_GAD_LHGDN |
| Proteinuria | 0.005091382 | 2 | 0 | GAD_LHGDN |
| HIV-Associated Lipodystrophy Syndrome | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Malignant neoplasm of esophagus | 0.004734064 | 2 | 0 | GAD |
| Kidney Diseases | 0.003810118 | 5 | 0 | BeFree_LHGDN |
| Colorectal Carcinoma | 0.003528744 | 13 | 3 | BeFree |
| Malignant neoplasm of breast | 0.003452799 | 5 | 1 | BeFree_GAD |
| Hyperglycemia | 0.003452799 | 5 | 2 | BeFree_GAD |
| Ovarian Diseases | 0.003257302 | 12 | 1 | BeFree |
| Lipodystrophy | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Degenerative polyarthritis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Prader-Willi Syndrome | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Cerebrovascular accident | 0.002909916 | 3 | 8 | BeFree_GAD |
| Pediatric Obesity | 0.002909916 | 2 | 1 | BeFree_GAD |
| Adenocarcinoma | 0.00272435 | 1 | 0 | LHGDN |
| Angina Pectoris | 0.00272435 | 1 | 0 | LHGDN |
| Angina Pectoris, Variant | 0.00272435 | 1 | 0 | LHGDN |
| Behcet Syndrome | 0.00272435 | 1 | 0 | LHGDN |
| Renal Cell Carcinoma | 0.00272435 | 1 | 0 | LHGDN |
| Chest Pain | 0.00272435 | 1 | 0 | LHGDN |
| Endometrial Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Graves Disease | 0.00272435 | 1 | 0 | LHGDN |
| Hypercholesterolemia, Familial | 0.00272435 | 1 | 0 | LHGDN |
| Hypoglycemia | 0.00272435 | 1 | 0 | LHGDN |
| Arthropathy | 0.00272435 | 1 | 0 | LHGDN |
| Leukemia, Myelocytic, Acute | 0.00272435 | 1 | 0 | LHGDN |
| Liver diseases | 0.00272435 | 1 | 0 | LHGDN |
| Lung Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Pancreatitis, Chronic | 0.00272435 | 1 | 0 | LHGDN |
| Aortic Aneurysm, Abdominal | 0.00272435 | 1 | 0 | LHGDN |
| Hypoalbuminemia | 0.00272435 | 1 | 0 | LHGDN |
| Disease Progression | 0.00272435 | 1 | 0 | LHGDN |
| Headache Disorders | 0.00272435 | 1 | 0 | LHGDN |
| Hepatitis C, Chronic | 0.00272435 | 1 | 0 | LHGDN |
| Hyperuricemia | 0.00272435 | 1 | 0 | LHGDN |
| Sjogren's Syndrome | 0.00272435 | 1 | 0 | LHGDN |
| Bulimia Nervosa | 0.00272435 | 1 | 0 | LHGDN |
| Infection | 0.00272435 | 1 | 0 | LHGDN |
| Hypoadiponectinemia | 0.002714419 | 10 | 2 | BeFree |
| Cardiomyopathy, Dilated | 0.002638474 | 1 | 0 | BeFree_GAD |
| HIV Infections | 0.002638474 | 1 | 0 | BeFree_GAD |
| Lupus Erythematosus, Systemic | 0.002638474 | 1 | 0 | BeFree_GAD |
| Schizophrenia | 0.002638474 | 2 | 0 | BeFree_GAD |
| Alzheimer's Disease | 0.002367032 | 1 | 0 | GAD |
| Cellulitis | 0.002367032 | 1 | 0 | GAD |
| Esophageal Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Lymphoma | 0.002367032 | 1 | 0 | GAD |
| Multiple Organ Failure | 0.002367032 | 1 | 0 | GAD |
| Pancreatitis | 0.002367032 | 1 | 0 | GAD |
| Pregnancy Complications | 0.002367032 | 1 | 0 | GAD |
| Hyperandrogenism | 0.002367032 | 1 | 0 | GAD |
| Electrocardiogram: P-R interval | 0.002367032 | 1 | 0 | GAD |
| Left ventricular mass | 0.002367032 | 1 | 0 | GAD |
| Insulin Sensitivity | 0.002367032 | 1 | 0 | GAD |
| Glucose Metabolism Disorders | 0.002367032 | 1 | 1 | GAD |
| Systemic arterial pressure | 0.002367032 | 1 | 0 | GAD |
| Proteinuria Adverse Event | 0.002367032 | 1 | 0 | GAD |
| Weight Loss Adverse Event | 0.002367032 | 1 | 0 | GAD |
| Malignant tumor of colon | 0.001628651 | 6 | 0 | BeFree |
| Colon Carcinoma | 0.001628651 | 6 | 0 | BeFree |
| Arteriosclerosis | 0.001357209 | 5 | 0 | BeFree |
| Obesity, Abdominal | 0.001085767 | 4 | 0 | BeFree |
| Breast Carcinoma | 0.001085767 | 4 | 1 | BeFree |
| Ischemic stroke | 0.001085767 | 4 | 0 | BeFree |
| Liver carcinoma | 0.001085767 | 4 | 1 | BeFree |
| Ischemic Cerebrovascular Accident | 0.001085767 | 4 | 0 | BeFree |
| Malignant neoplasm of endometrium | 0.000814326 | 3 | 0 | BeFree |
| Congestive heart failure | 0.000814326 | 3 | 0 | BeFree |
| Essential Hypertension | 0.000814326 | 3 | 0 | BeFree |
| Endometrial Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Prostate carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Conn Syndrome | 0.000814326 | 3 | 1 | BeFree |
| Uterine Corpus Cancer | 0.000814326 | 3 | 0 | BeFree |
| Insulin resistance syndrome | 0.000814326 | 3 | 0 | BeFree |
| Adenoma | 0.000542884 | 2 | 0 | BeFree |
| Cerebral Infarction | 0.000542884 | 2 | 8 | BeFree |
| Liver neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Lung diseases | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of stomach | 0.000542884 | 2 | 0 | BeFree |
| Pancreatic carcinoma | 0.000542884 | 2 | 1 | BeFree |
| Adenocarcinoma Of Esophagus | 0.000542884 | 2 | 2 | BeFree |
| Malignant neoplasm of pancreas | 0.000542884 | 2 | 1 | BeFree |
| Stomach Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Chronic kidney disease stage 5 | 0.000542884 | 2 | 0 | BeFree |
| Anorexia | 0.000271442 | 1 | 0 | BeFree |
| Noninfiltrating Intraductal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mental Depression | 0.000271442 | 1 | 1 | BeFree |
| Depressive disorder | 0.000271442 | 1 | 1 | BeFree |
| Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis A | 0.000271442 | 1 | 0 | BeFree |
| Ischemia | 0.000271442 | 1 | 0 | BeFree |
| leukemia | 0.000271442 | 1 | 0 | BeFree |
| Myeloid Leukemia, Chronic | 0.000271442 | 1 | 0 | BeFree |
| Meningioma | 0.000271442 | 1 | 0 | BeFree |
| Kidney Failure | 0.000271442 | 1 | 0 | BeFree |
| Respiratory Distress Syndrome, Adult | 0.000271442 | 1 | 0 | BeFree |
| Retinal Diseases | 0.000271442 | 1 | 0 | BeFree |
| Seizures | 0.000271442 | 1 | 0 | BeFree |
| Werner Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Familial generalized lipodystrophy | 0.000271442 | 1 | 0 | BeFree |
| Gastrointestinal Stromal Tumors | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of lung | 0.000271442 | 1 | 0 | BeFree |
| Chronic heart failure | 0.000271442 | 1 | 0 | BeFree |
| Conventional (Clear Cell) Renal Cell Carcinoma | 0.000271442 | 1 | 1 | BeFree |
| stage, gastric cancer | 0.000271442 | 1 | 0 | BeFree |
| Cervix carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Restenosis | 0.000271442 | 1 | 0 | BeFree |
| Insulin resistance in diabetes | 0.000271442 | 1 | 0 | BeFree |
| Osteoarthritis, Knee | 0.000271442 | 1 | 0 | BeFree |
| Atypical meningioma | 0.000271442 | 1 | 0 | BeFree |
| Carcinogenesis | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
| Carotid Artery Plaque | 0.000271442 | 1 | 0 | BeFree |
| Endothelial dysfunction | 0.000271442 | 1 | 0 | BeFree |
| Macroangiopathy | 0.000271442 | 1 | 0 | BeFree |
| CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5 | 0.000271442 | 1 | 0 | BeFree |
| Brooke-Spiegler syndrome | 0.000271442 | 1 | 0 | BeFree |
| Steatohepatitis | 0.000271442 | 1 | 0 | BeFree |
| Obesity, Visceral | 0.000271442 | 1 | 0 | BeFree |
| Arteriosclerotic cardiovascular disease, NOS | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。